NCCN and Flatiron Health Renew Collaboration to Advance Real-World Cancer Data Research
Flatiron Health and NCCN Renew Collaboration to Expand Real-World Evidence Research in Oncology Flatiron Health, a leading healthtech company focused on improving cancer care and advancing oncology research through real-world…
Gossamer Bio Announces 1-for-80 Reverse Stock Split
Gossamer Bio Announces 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for pulmonary vascular diseases,…
PhenoNet Completes Phase IIb ALS Trial Recruitment and Randomization
PhenoNet Completes Enrollment in Phase IIb Trial of PHENOGENE-1A for ALS PhenoNet, Inc., a clinical-stage biotechnology company developing investigational therapies for neurodegenerative diseases, has announced the completion of recruitment and…
TwoStep Therapeutics Raises $62.5M Series A and Secures FDA IND Clearance for First-in-Class Peptide-Drug Conjugate
TwoStep Therapeutics Secures $62.5 Million Series A and FDA Clearance for TS-104 Phase 1 Trial TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, has announced two…
Lotus Neuro Launches to Advance Next-Generation Blood-Brain Barrier Therapies
Lotus Neuro Launches to Advance Focused Ultrasound Drug Delivery for Neurological Diseases Lotus Neuro, a clinical-stage biotechnology company focused on combining focused ultrasound with therapeutic medicines to address focal neurological…
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Cancer Treatment
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Multiple Cancers Crossbow Therapeutics, Inc., a biotechnology company developing targeted antibody therapies designed to address a broad range…
Gilead Opens Advanced Research Center to Accelerate Next-Generation Medicines
Gilead Sciences Opens New Research Center in Foster City to Accelerate Biomedical Innovation Gilead Sciences, Inc. (Nasdaq: GILD) has officially opened a new 182,000-square-foot Research Center at its headquarters in…
Foot Levelers Announces First Chiropractic PracticeXcelerator® Continuing Education and Headquarters Tour
Foot Levelers Announces First-Ever Founder’s Edition PracticeXcelerator Workshop for Chiropractors Foot Levelers, a global leader in custom stabilizing orthotics, has announced its first-ever Founder’s Edition event, an expanded educational and…
restor3d Launches MyFit Digital Suite to Expand Personalized Orthopedic Care
restor3d Launches MyFit Digital Suite to Enhance Personalized Orthopedic Patient Experience restor3d, a leader in personalized 3D-printed orthopedic solutions, has announced the launch of MyFit by restor3d Digital Suite, a…
Nanochon Performs First Procedure in Chondrograft™ First-in-Human Clinical Study
Nanochon Treats First Patient in First-in-Human Clinical Study of Chondrograft for Knee Cartilage Defects Nanochon, a medical device company developing innovative solutions for cartilage repair, has announced the successful treatment…
RMA New Jersey Welcomes Reproductive Endocrinologist Dr. Blake Vessa to Expand Fertility Care
IVI RMA North America Welcomes Reproductive Endocrinologist Dr. Blake Vessa to RMA New Jersey IVI RMA North America, a leader in fertility care and assisted reproductive medicine, has announced the…
Sarepta Therapeutics Announces 2026-2027 Route 79 Duchenne Scholarship Recipients
Sarepta Therapeutics Announces 25 Recipients of Route 79 Duchenne Scholarship Program for 2026-2027 Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a company focused on precision genetic medicine for rare diseases, has announced…